quinazolines has been researched along with Neoplasms, Skull Base in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amary, MF; Athanasou, N; Bacsi, K; Berisha, F; Briggs, TR; Flanagan, AM; Halai, D; Hogendoorn, PC; Idowu, B; Kindblom, LG; Leithner, A; Liegl, B; Presneau, N; Shalaby, A; Tirabosco, R; Ye, H | 1 |
1 other study(ies) available for quinazolines and Neoplasms, Skull Base
Article | Year |
---|---|
The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Proliferation; Chordoma; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; ErbB Receptors; Humans; In Situ Hybridization, Fluorescence; Mutation; Neoplasm Proteins; Quinazolines; Receptor Protein-Tyrosine Kinases; Receptor, ErbB-2; Skull Base Neoplasms; Tumor Cells, Cultured; Tyrphostins | 2011 |